| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/25/2000 | WO2000016761A3 Serotonergic 5ht2 agonists for treating glaucoma |
| 05/25/2000 | WO2000012111A3 Selective treatment of endothelial somatostatin receptors |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 05/25/2000 | CA2350532A1 Excitatory amino acid receptor modulators |
| 05/25/2000 | CA2349575A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001955A1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 05/24/2000 | EP1001785A1 Use of colchinol derivatives as vascular damaging agents |
| 05/24/2000 | EP0671879B1 Prevention of injury and degeneration of photoreceptors by neurotrophic factors |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1253822A Chinese patent medicine for curing myopia |
| 05/24/2000 | CN1253821A Chinese patent medicine for curing senile cataract |
| 05/24/2000 | CN1052647C Yanming bag-soaking oral preparation for eye health care and making method thereof |
| 05/23/2000 | US6066717 RsbW-1 protein |
| 05/23/2000 | US6066671 Topical administration to the eye |
| 05/23/2000 | US6066657 For the treatment of disease states associated with proteins which mediate cellular activity, for example by inhibiting tumor necrosis factor or phosphodiesterase iv |
| 05/23/2000 | US6066652 Method for treating diseases of the inner ear using adamantane derivatives |
| 05/23/2000 | US6066617 Polypeptide |
| 05/23/2000 | CA2200959C 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives |
| 05/23/2000 | CA2010578C Piperidine compounds and their preparation and use |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000027887A2 Cross-linked hyaluronic acids and medical uses thereof |
| 05/18/2000 | WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | WO2000027866A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
| 05/18/2000 | WO2000027822A2 Tricyclic pyrazole derivatives |
| 05/18/2000 | WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/18/2000 | WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | WO2000027430A2 Composition consisting of influenza virus surface proteins and dispensing device |
| 05/18/2000 | WO2000027426A1 Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors |
| 05/18/2000 | WO2000027424A2 Upregulation of endogenous prostaglandins to lower intraocular pressure |
| 05/18/2000 | WO2000027421A2 LOCAL USE OF SOLUBLE TUMOR NECROSIS RECEPTOR I (sTNFRI) FOR PROPHYLAXIS AND TREATMENT OF CORNEAL TRANSPLANT REJECTION AND OTHER DISORDERS OF THE EYE |
| 05/18/2000 | WO2000027414A2 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | WO2000027402A1 Remedies for topical administration for iv type allergic diseases |
| 05/18/2000 | WO2000027395A1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 05/18/2000 | WO2000027394A1 Activators of soluble guanylate cyclase |
| 05/18/2000 | WO2000027392A1 Chromone enteric release formulation |
| 05/18/2000 | WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders |
| 05/18/2000 | WO2000009108A3 Compositions and uses for vision and memory disorders |
| 05/18/2000 | WO2000009098A3 Method for treating ocular neovascular diseases |
| 05/18/2000 | WO2000008141A3 Short oligonucleotides for the inhibition of vegf expression |
| 05/18/2000 | WO2000008140A3 Antisense oligonucleotides for the inhibition of vegf expression |
| 05/18/2000 | WO1999058096A3 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 05/18/2000 | CA2350915A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
| 05/18/2000 | CA2350667A1 Cross-linked hyaluronic acids and medical uses thereof |
| 05/18/2000 | CA2350235A1 Tricyclic pyrazole derivatives |
| 05/18/2000 | CA2350211A1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 05/18/2000 | CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/17/2000 | EP1000930A2 Tachykinin antagonists |
| 05/17/2000 | EP1000927A2 Excitatory amino acid receptor modulators |
| 05/17/2000 | EP1000627A1 Aqueous preparation of lactoferrin having improved stability |
| 05/17/2000 | EP1000619A2 Method for treating glaucoma |
| 05/17/2000 | EP1000144A2 Lactoferrin receptor genes of moraxella |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | EP1000008A1 Novel thyroid receptor ligands and method |
| 05/17/2000 | EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | EP0999825A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/17/2000 | CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction |
| 05/17/2000 | CN1253560A Sulfonamides for treatment of endothelin-mediated disorders |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253553A Substituted phenyl derivatives, their preparation and use |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253508A Topical nasal antiinflammatory compositions |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/16/2000 | US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor |
| 05/16/2000 | US6063796 Heterocyclic compounds of piperidine |
| 05/16/2000 | US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063116 Modulation of cell proliferation and wound healing |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026367A2 Therapeutics and diagnostics for ocular abnormalities |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026167A1 Vitamin d analogues |
| 05/11/2000 | WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000025788A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 05/11/2000 | WO2000025786A1 Heterocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000025774A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | WO2000025771A1 Method for preventing increased iridial pigmentation during prostaglandin treatment |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |